ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

NEAD Chains Do Not Disadvantage Blood Type O, Black, or Highly Sensitized Patients.

M. Rees,1 J. Roberts,2 K. Lentine,3 A. Roth,4 A. Leichtman,5 H. Xiao,3 S. Rafizadeh,1 E. Neidich,2 M. Melcher.4

1UT, Toledo
2UCSF, SF
3SLU, St Louis
4Stanford, Palo Alto
5Arbor Res, Ann Arbor.

Meeting: 2016 American Transplant Congress

Abstract number: A116

Keywords: Allocation, Donors, Kidney transplantation, Public policy, unrelated

Session Information

Session Name: Poster Session A: Kidney Donor Outcomes

Session Type: Poster Session

Date: Saturday, June 11, 2016

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Halls C&D

Introduction: NEAD chains raised concern that wait-listed blood type (BT) O patients and racial minorities would be disadvantaged by allocation of a non-directed donor (NDD) kidney to someone other than the wait-list (WL) candidate who would have been the top person on the deceased donor (DD) match run for that kidney.

Methods: We retrospectively examined candidates on the DD WL and Rs of DD, living donor (LD), and KPD kidney transplants (KTx) from January 1, 2000 – June 28, 2013 using OPTN STAR Files. Distributions of patient race, BT, and PRA within each of these cohorts was calculated as proportions using SAS. Differences in distributions of characteristics across Rs of each KTx type were compared by Chi-square. Separately, we modeled using DD as NEAD chain-initiating kidneys (DD-CIK) to produce chains using historical data from a KPD registry, the KTx WL and the OPTN STAR files covering DD KTx performed from May 18, 2010 and June 28, 2013. Only 2-way DD-CIK chains were allowed ending with the actual historical OPTN allocation R.

Results: The racial distribution of KPD Rs is more similar to LD than to DD. For example, black Rs comprise 14.2%, 14.1%, and 30.5% of KPD, LD and DD Rs. Similar to LD, KPD Rs were less likely than DD Rs to have BT-O (40.5% vs. 45.3%), but more likely to have BT-B (19.2% vs. 12.8%). However, while the percentage of BT O Rs and black Rs was less with KPD than with DD, the total number of BT O and black Rs transplanted per NDD was higher than would have been achieved through allocation of the NDD kidney utilizing the prior OPTN DD kidney allocation system. A higher proportion of Rs transplanted by KPD were sensitized than those transplanted by conventional LD and DD. Simulating the matching of historical OPTN DDs into a KPD registry to produce DD-CIK chains with two Rs, produced the following results: 329 DD kidneys out of 18,000 were utilized as DD-CIK. Instead of these 329 DD kidneys producing 329 KTx, 658 KTx were possible if DD-CIK were available to the KPD matching system, in addition to the 424 KTx achieved by traditional KPD alone.

Conclusion: NEAD chains have not disadvantaged BT O, black or highly sensitized patients. In a simulation, twice as many patients and more highly sensitized patients and BT O patients were transplanted through DD-CIK allocation than by the historical OPTN allocation used at the time.

CITATION INFORMATION: Rees M, Roberts J, Lentine K, Roth A, Leichtman A, Xiao H, Rafizadeh S, Neidich E, Melcher M. NEAD Chains Do Not Disadvantage Blood Type O, Black, or Highly Sensitized Patients. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Rees M, Roberts J, Lentine K, Roth A, Leichtman A, Xiao H, Rafizadeh S, Neidich E, Melcher M. NEAD Chains Do Not Disadvantage Blood Type O, Black, or Highly Sensitized Patients. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/nead-chains-do-not-disadvantage-blood-type-o-black-or-highly-sensitized-patients/. Accessed July 1, 2025.

« Back to 2016 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences